Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review

A Bougea, C Koros, L Stefanis - Journal of Neural Transmission, 2019 - Springer
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …
被引用次数：46 相关文章

Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review

A Bougea, C Koros, L Stefanis - Journal of neural …, 2019 - pubmed.ncbi.nlm.nih.gov
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …
[PDF] academia.edu

[PDF][PDF] Salivary alpha‑synuclein as a biomarker for Parkinson's disease: a systematic review

A Bougea, C Koros, L Stefanis - 2019 - academia.edu
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …

Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review

A Bougea, C Koros, L Stefanis - Journal of Neural Transmission, 2019 - infona.pl
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …

Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.

A Bougea, C Koros, L Stefanis - Journal of Neural …, 2019 - search.ebscohost.com
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …

Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.

A Bougea, C Koros, L Stefanis - Journal of Neural Transmission …, 2019 - europepmc.org
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …
[PDF] academia.edu

[PDF][PDF] Salivary alpha‑synuclein as a biomarker for Parkinson's disease: a systematic review

A Bougea, C Koros, L Stefanis - 2019 - academia.edu
The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …